Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027651 (
tumor
)
685,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Eight renal oncocytomas are described. Clinical manifestations were present in 3 cases, with hematuria occurring in 2 and flank pain in 2.
Tumors
were between 2.5 and 10.0 cm. in diameter and showed considerable variation in histologic pattern. The tan coloration of some tumors may permit a naked-eye distinction from
renal cell carcinoma
. All tumors appeared to be benign.
...
PMID:Renal oncocytoma. Study of eight cases. 47 72
Vascular perfusion of 16 renal adenocarcinomas with radioactive DNA precursors provides a possibility of characterize proliferative compartments of this
tumor
type. Immediately after resection of the
tumor
-bearing kidney, the organ is perfused via renal artery with dextran-diluted, heparinized oxygenated blood at physiological temperature, pH, flow, and pressure in a recirculation system. DNA synthetizing cells are labeled by addition of 3H- or 14C-thymidine or both isotopes at different intervals. Beta camera scans and whole-
tumor
autoradiograms disclose a striking proliferative heterogeneity of the
tumor
. Cell proliferation depends on intratumoral localization, cellular differentiation, histological structure and vascular supply. Subpopulations of high proliferative activity are found at the invasive borderline near normal kidney, focally in subcapsular areas and in intrarenal metastases, but also immediately adjacent to necrotic areas in the
tumor
center. Quantitative evaluation of autoradiograms yields, at the cellular level, a significantly higher labeling index in granular cells (3.21%) than in clear cells (0.65%), with a large variability dependent on the histological structure. The highest number of DNA synthetizing cells is seen in papillary and mixed solid-tubular zones and at peripheral parts of solid areas, whereas in central parts of solid tumor cords and in highly differentiated tubular areas lower labeling indices are observed. The labeling index decreases exponentially as a function of the distance from the supporting blood vessel. In solid cords, no labeled cells are seen at a distance of more than 200 micron from the capillary. The ts determined by 3H/14C-thymidine double labeling is between 9.9 and 16.8 hr for granular cells and about 9.2 hr for clear cells. Potential population doubling time calculated for various subpopulations yields values between 4 and 50 days. It is concluded that cell loss is high, for granular cells in particular. Besides cell loss, a large nonproliferating compartment contributes to a delay of the
tumor
volume doubling time. Proliferative heterogeneity of advanced human tumors, as exemplified by the
renal adenocarcinoma
, bears important implications for therapy and prognosis.
...
PMID:Analysis of proliferative compartments in human tumors. I. Renal adenocarcinoma. 47 95
The early (dynamic) and late (static) renal images obtained with 99mTc-dimercaptosuccinic acid (DMSA) were utilized to evaluate renal cortical malignant tumors in 30 cases of
renal cell carcinoma
each of which had been confirmed by operation or autopsy. Early images, performed 20--50 seconds after radionuclide administration, demonstrated abnormal vascular pools in the cortex. A cold area without DMSA uptake was demonstrated on the 2-hour or late images, reflecting a non-functioning renal mass. Lesions demonstrated with combined early and late images showed a good correlation with those demonstrated by renal angiography in 25 out of 27 cases. However, when almost all the renal
tumor
was replaced by necrotic lesions, the early image did not reveal hypervascularity. When a highly vascular renal
tumor
extended to the perinephric tissues, the
tumor
area was sometimes overestimated on the early image. It is almost impossible to diagnose
renal cell carcinoma
using radionuclide imaging alone. However, 99mTc-DMSA renal studies, using both early and late imaging, have proven to be a useful, noninvasive adjunct in the detection of malignant cortical lesions.
...
PMID:Successful visualization of cortical malignant lesions on renal scintigram using 99mTc-dimercaptosuccinic acid. 47 42
Bilateral
renal cell carcinoma
, malignant tumors of a solitary kidney or
renal carcinoma
in the presence of a contralateral kidney with compromised function may be treated by simple enucleation of the
tumor
, usually pseudoencapsulated, permitting relatively avascular removal. We treated 5 such patients by surgical enucleation of
renal cell carcinoma
who have survived for intervals of 9 months to 5 years without evidence of recurrent local or metastic disease. The simplicity of the technique offers several advantages, primarily those of applicability to lesions of any portion of the kidney and the minimal disturbance of renal hemodynamics and renal function.
...
PMID:Enucleative surgery for renal malignancy. 48 May 3
A 26-year-old woman had a neuroblastoma during infancy; an extra-adrenal pheochromocytoma at age 16 years, with hepatic recurrences during the next ten years; and multifocal
renal cell carcinoma
. Neuroblastoma and pheochromocytoma, despite their common embryologic origin, to our knowledge have not been previously reported as separate tumors in the same patient. Although many attributes of the patient's tumors suggest a hereditary disorder, thorough investigation disclosed no evidence of heritable conditions associated with any of these tumors in the patient or her family members. Long-term observation of persons surviving after treatment of neuroblastoma will be necessary to determine whether this case represents a previously unidentified
tumor
predisposition or a sporadic occurrence.
...
PMID:Neuroblastoma, pheochromocytoma, and renal cell carcinoma. Occurrence in a single patient. 49 Aug 9
Inferior vena cavography plays an important role in the staging of
renal cell carcinoma
. The renal angiograms and inferior vena cavograms in a series of patients with
renal cell carcinoma
were reviewed to determine which patients require cavography. Our findings show that renal angiography is of great value in suggesting
tumor
involvement of the renal vein or vena cava, and that the decision to do cavography can be made from the angiographic findings. In the series of 172 patients with
renal carcinoma
, 15 or 9% had inferior vena cava involvement.
...
PMID:Involvement of the inferior vena cava in patients with renal cell carcinoma. 49 17
Thorotrast deposts produce intense fibrosis and it is not uncommon for malignant tumors to arise in such cases. Thus for example,
renal carcinoma
was observed 35 years after administration of Thorotrast. Such carcinomas may be difficult to diagnose in time because of radiogenic nephritis. In the light of experience with a 55-year old man, the reason for delayed carcinoma diagnosis was lack of formation of
tumor
nodes due to intense fibrosis resulting in diffuse and canalicular
tumor
spread. Hence it is obvious that angiography may not be diagnostic in such cases.
...
PMID:[Thorotrastosis and thorotrast carcinoma of the kidney. A differential diagnostic problem]. 49 13
The authors reviewed the records of eight children with
renal cell carcinoma
and correlated the clinical presentation, pathological and radiologic findings, stage and treatment of the disease with patient survival. Angiography revealed tumours of sparse neovascularity, associated with varied histologic patterns. Patient survival was dependent on the stage of the disease at the time of treatment; treatment of localized disease was effective but of metastatic disease was generally poor.
Tumour
staging appeared to be the only reliable indicator of prognosis. Children with
renal cell carcinoma
differ from adults in that a palpable mass in a child does not necessarily indicate that there is metastatic disease.
...
PMID:Renal cell carcinoma in children. 49 8
One hundred and forty-seven fully and partially evaluable patients with advanced measurable malignancies of the genitourinary and gynecologic organs were given cis-dichlorodiammineplatinum(II) at a dose of 75 mg/m2 iv every 3 weeks. Thirty-six patients with testicular neoplasms were studied; five complete responses (13.9%) and seven partial responses (PR) (19.4%) were noted. Thirty-seven patients with ovarian adenocarcinoma were evaluated; five PRs (13.5%) were seen. One complete response (11.1%) and two PRs (22.2%) were obtained among nine patients with urinary bladder cancer. Four PRs (19.0%) were seen among a group of 21 patients with advanced prostate cancer. One PR (4.8%) was noted among 21 patients with
renal cell cancer
and no responses were seen in eight patients with cervical cancer. There was a highly statistically significant (P less than 0.001) survival advantage for the responding testicular
tumor
patients. Toxicity was similar to that previously reported, with gastrointestinal side effects and nephrotoxicity most commonly seen. Prospective and sequential analysis of renal function provided strong evidence for cumulative nephrotoxicity in these patients given bolus injections of cis-dichlorodiammineplatinum(II) without prehydration or treatment with fuosemide or mannitol.
...
PMID:Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study. 49 55
We submitted to computer analysis 109 items of pathologic, clinical and survival data from 96 patients with
renal carcinoma
treated by nephrectomy with or without adjuvant therapy between 1956 and 1976. The combined 1, 5 and 10-year calculated survival rates for potentially curable non-metastatic
renal carcinoma
(stages I, II and III, provided the regional lymph nodes were not involved) were 95, 61 and 47 per cent, respectively, compared to 1, 5 and 10-year survival rates of 61, 5 and 0 per cent, respectively, for stage IV tumors. The cytoplasmic appearance (clear or granular) was not a significant microscopic feature relevant to survival of the patient but the grade of the
tumor
was predictive of the outcome of disease. Other features of
renal carcinoma
, particularly invasion of the renal vein and, to a lesser degree, perinephric fat, were not as prognostically significant in this series. In this retrospective study we further analyze the clinical, radiologic, pathologic and survival data of this group of patients.
...
PMID:Renal carcinoma: computer analysis of 96 patients treated by nephrectomy. 50 10
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>